François Ventura

François is a specialist in Anesthesiology, Intensive Care Medicine, and Emergency Medicine. He has been working at the University Hospitals of Geneva since 1999 and has held successive positions as assistant physician, resident, associate physician, and consultant physician in the Department of Anesthesiology and in the Adult Intensive Care Unit. He has also gained extensive clinical experience working independently in private clinics. During the first Covid wave in March 2020, he studied the daily dosage of the Pancreatic Stone Protein PSP in critically ill patients hospitalized in the adult intensive care unit of the University Hospital of Geneva. Since then, he has published articles on biomarkers of sepsis and PSP. He collaborates also part-time with a MedTech company that specialized in nanofluidic new and classical biomarkers analysis.